Please login to the form below

Not currently logged in
Email:
Password:

Barry Labinger joins Biothera Pharmaceutical

Brings experience from Human Genome Sciences and 3M Pharmaceuticals
Biothera Pharmaceutical Barry Labinger

US biotech company Biothera Pharmaceutical has appointed Barry Labinger as its new chief executive officer.

Labinger has nearly three decades of pharmaceutical and biotech industry experience, with roles at Emergent BioSolutions, Human Genome Sciences, 3M Pharmaceuticals and Immunex.

His experience with oncology drug development will be particularly useful to the Minnesota-based firm, which is developing a novel cancer immunotherapy.

Richard Mueller, chairman of the board at Biothera Holding Corp, said: “Barry has strong leadership and management skills to take Biothera Pharmaceutical forward and realise the full potential of Imprime PGG, the company's first-in-class immune modulator, which we believe is the next step in immune oncology.

“We are delighted to have such an accomplished executive lead the company through the next phase of its development.”

Labinger most recently served as executive vice president and president, Biosciences Division, at Emergent BioSolutions Inc., where he was responsible for all aspects of product development, manufacturing, and commercialisation.

14th December 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...